These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28624335)

  • 1. Neuropathologic features of TOMM40 '523 variant on late-life cognitive decline.
    Yu L; Lutz MW; Farfel JM; Wilson RS; Burns DK; Saunders AM; De Jager PL; Barnes LL; Schneider JA; Bennett DA
    Alzheimers Dement; 2017 Dec; 13(12):1380-1388. PubMed ID: 28624335
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Yu L; Lutz MW; Wilson RS; Burns DK; Roses AD; Saunders AM; Gaiteri C; De Jager PL; Barnes LL; Bennett DA
    Neurology; 2017 Feb; 88(7):661-668. PubMed ID: 28108637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936.
    Lyall DM; Harris SE; Bastin ME; Muñoz Maniega S; Murray C; Lutz MW; Saunders AM; Roses AD; Valdés Hernández Mdel C; Royle NA; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
    Neurobiol Aging; 2014 Jun; 35(6):1513.e25-33. PubMed ID: 24508314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging.
    Hayden KM; McEvoy JM; Linnertz C; Attix D; Kuchibhatla M; Saunders AM; Lutz MW; Welsh-Bohmer KA; Roses AD; Chiba-Falek O
    Alzheimers Dement; 2012 Sep; 8(5):381-8. PubMed ID: 22863908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ε3/ε3 genotype.
    Johnson SC; La Rue A; Hermann BP; Xu G; Koscik RL; Jonaitis EM; Bendlin BB; Hogan KJ; Roses AD; Saunders AM; Lutz MW; Asthana S; Green RC; Sager MA
    Alzheimers Dement; 2011 Jul; 7(4):456-65. PubMed ID: 21784354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotypic Effects of the TOMM40'523 Variant and APOE on Longitudinal Cognitive Change over 4 Years: The TOMMORROW Study.
    Zou H; Luo S; Liu H; Lutz MW; Bennett DA; Plassman BL; Welsh-Bohmer KA
    J Prev Alzheimers Dis; 2023; 10(4):886-894. PubMed ID: 37874111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of TOMM40 on spatial navigation in amnestic mild cognitive impairment.
    Laczó J; Andel R; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Lerch O; Gazova I; Moffat SD; Hort J
    Neurobiol Aging; 2015 Jun; 36(6):2024-33. PubMed ID: 25862420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cis-regulatory effect of an Alzheimer's disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes.
    Linnertz C; Anderson L; Gottschalk W; Crenshaw D; Lutz MW; Allen J; Saith S; Mihovilovic M; Burke JR; Welsh-Bohmer KA; Roses AD; Chiba-Falek O
    Alzheimers Dement; 2014 Sep; 10(5):541-51. PubMed ID: 24439168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease susceptibility genes APOE and TOMM40, and hippocampal volumes in the Lothian birth cohort 1936.
    Lyall DM; Royle NA; Harris SE; Bastin ME; Maniega SM; Murray C; Lutz MW; Saunders AM; Roses AD; del Valdés Hernández MC; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
    PLoS One; 2013; 8(11):e80513. PubMed ID: 24260406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes.
    Greenbaum L; Springer RR; Lutz MW; Heymann A; Lubitz I; Cooper I; Kravitz E; Sano M; Roses AD; Silverman JM; Saunders AM; Beeri MS
    Eur Neuropsychopharmacol; 2014 Sep; 24(9):1492-9. PubMed ID: 25044051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TOMM40 intron 6 poly-T length, age at onset, and neuropathology of AD in individuals with APOE ε3/ε3.
    Li G; Bekris LM; Leong L; Steinbart EJ; Shofer JB; Crane PK; Larson EB; Peskind ER; Bird TD; Yu CE
    Alzheimers Dement; 2013 Sep; 9(5):554-61. PubMed ID: 23183136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal modeling of cognitive aging and the TOMM40 effect.
    Caselli RJ; Dueck AC; Huentelman MJ; Lutz MW; Saunders AM; Reiman EM; Roses AD
    Alzheimers Dement; 2012 Nov; 8(6):490-5. PubMed ID: 23102119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TOMM40-APOE haplotypes are associated with cognitive decline in non-demented Blacks.
    Deters KD; Mormino EC; Yu L; Lutz MW; Bennett DA; Barnes LL
    Alzheimers Dement; 2021 Aug; 17(8):1287-1296. PubMed ID: 33580752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis.
    Gang Q; Bettencourt C; Machado PM; Fox Z; Brady S; Healy E; Parton M; Holton JL; Hilton-Jones D; Shieh PB; Zanoteli E; De Paepe B; De Bleecker J; Shaibani A; Ripolone M; Violano R; Moggio M; Barohn RJ; Dimachkie MM; Mora M; Mantegazza R; Zanotti S; Hanna MG; Houlden H;
    Neurobiol Aging; 2015 Apr; 36(4):1766.e1-1766.e3. PubMed ID: 25670332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TOMM40 '523' polymorphism in disease risk and age of symptom onset in two independent cohorts of Parkinson's disease.
    Bakeberg MC; Hoes ME; Gorecki AM; Theunissen F; Pfaff AL; Kenna JE; Plunkett K; Kõks S; Akkari PA; Mastaglia FL; Anderton RS
    Sci Rep; 2021 Mar; 11(1):6363. PubMed ID: 33737565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TOMM40 rs10524523 polymorphism's role in late-onset Alzheimer's disease and in longevity.
    Maruszak A; Pepłońska B; Safranow K; Chodakowska-Żebrowska M; Barcikowska M; Zekanowski C
    J Alzheimers Dis; 2012; 28(2):309-22. PubMed ID: 22008263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles.
    Bennett DA; De Jager PL; Leurgans SE; Schneider JA
    Neurology; 2009 Apr; 72(17):1495-503. PubMed ID: 19398704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family history and TOMM40 '523 interactive associations with memory in middle-aged and Alzheimer's disease cohorts.
    Willette AA; Webb JL; Lutz MW; Bendlin BB; Wennberg AM; Oh JM; Roses A; Koscik RL; Hermann BP; Dowling NM; Asthana S; Johnson SC;
    Alzheimers Dement; 2017 Nov; 13(11):1217-1225. PubMed ID: 28549947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms.
    Mastaglia FL; Rojana-udomsart A; James I; Needham M; Day TJ; Kiers L; Corbett JA; Saunders AM; Lutz MW; Roses AD;
    Neuromuscul Disord; 2013 Dec; 23(12):969-74. PubMed ID: 24103330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD; Fisk JD; Rockwood K
    Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.